DADC
ICPT

D.A. Davidson & Co’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

D.A. Davidson & Co’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,420
Closed -$278K – 1034
2020
Q1 		$278K Sell
4,420
-2,146
-33% -$193K 0.01% 773
2019
Q4 		$814K Buy
6,566
+3,161
+93% +$283K 0.01% 562
2019
Q3 		$226K Buy
+3,405
New +$229K ﹤0.01% 886

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

D.A. Davidson & Co's ICPT Position: Q2 2020 in Review

D.A. Davidson & Co sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2020, closing a stake of 4,420 shares — an estimated $278K sold.

D.A. Davidson & Co first reported a position in ICPT in Q3 2019 and held it in 3 quarters. The position peaked at $814K in Q4 2019. 192 funds tracked by Wall St. Rank hold ICPT as of Q2 2020.

  • D.A. Davidson & Co reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • D.A. Davidson & Co sold 4,420 Intercept Pharmaceuticals, Inc. shares in Q2 2020, an estimated $278K.
  • D.A. Davidson & Co first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2019 and held it in 3 quarters.
  • D.A. Davidson & Co's Intercept Pharmaceuticals, Inc. position peaked at $814K in Q4 2019.
  • 192 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2020.

Based on D.A. Davidson & Co's 13F filing for Q2 2020, filed 10 Aug 2020.